 This study builds on data that high-density lipoprotein HDL has a number of potentially beneficial effects including directly modulating glucose metabolism through multiple mechanisms. The primary objective of this study is to determine the effects of RVX000222 on postprandial plasma glucose in male individuals with impaired fasting glucose IFG or impaired glucose tolerance IGT, during a frequently sampled oral glucose tolerance test OGTT. 